Schonfeld Strategic Advisors LLC Biogen Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 7,211 shares of BIIB stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,211

Previous 6,870 4.96%

Holding current value

$1.07 Million

Previous $1.59 Million 12.25%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $64,472 - $80,748	341 Added 4.96%	7,211 $1.4 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $258,726 - $321,465	1,358 Added 24.64%	6,870 $1.59 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $425,736 - $537,561	-2,008 Reduced 26.7%	5,512 $1.19 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.27 Million - $1.52 Million	5,685 Added 309.81%	7,520 $1.95 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $464,805 - $524,608	1,835 New	1,835 $471,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $925,155 - $1.05 Million	3,606 Added 31.36%	15,106 $4.2 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.03 Million - $1.26 Million	4,096 Added 55.32%	11,500 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.93 Million - $6.8 Million	-25,340 Reduced 77.39%	7,404 $1.98 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $61,138 - $72,704	326 Added 1.01%	32,744 $6.68 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $257,907 - $324,950	1,331 Added 4.28%	32,418 $6.83 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $5.94 Million - $7.64 Million	26,532 Added 582.48%	31,087 $7.46 Million
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $10.2 Million - $13.4 Million	-36,179 Reduced 88.82%	4,555 $1.29 Million
Q2 2021 Nov 16, 2021	SELL	$259.0 - $414.71 $802,900 - $1.29 Million	-3,100 Reduced 7.07%	40,734 $14.1 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $9.75 Million - $15.6 Million	37,629 Added 606.43%	43,834 $15.2 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $802,949 - $940,702	3,305 Added 113.97%	6,205 $1.74 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $3.93 Million - $5.92 Million	-16,649 Reduced 85.17%	2,900 $710,000
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $2.32 Million - $2.68 Million	8,767 Added 81.31%	19,549 $6,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $2.14 Million - $2.84 Million	8,280 Added 330.94%	10,782 $2.89 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $1.56 Million - $1.98 Million	-5,808 Reduced 69.89%	2,502 $792,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $8.74 Million - $12.1 Million	-39,734 Reduced 82.7%	8,310 $2.47 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $7.02 Million - $7.88 Million	32,294 Added 205.04%	48,044 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $2.68 Million - $2.95 Million	12,216 Added 345.67%	15,750 $3.68 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $765,853 - $1.2 Million	3,534 New	3,534 $835,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $195,507 - $247,630	-702 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $206,044 - $269,448	702 New	702 $248,000
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $5.2 Million - $7.36 Million	-20,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $5.29 Million - $5.93 Million	-17,200 Reduced 46.24%	20,000 $6.37 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $10.5 Million - $12.3 Million	37,200	37,200 $11.6 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Biogen Inc. Transaction History